Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason A Weesner

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Methods in Enzymology|March 1, 2026
Imaging and quantifying organelle contact sites using a reversible splitFAST complementation systemJason A Weesner, Chi-Lun Chang
STAR Protocols|August 10, 2024
Protocol for the isolation and purification of endoplasmic reticulum-plasma membrane junctions from the mouse brainJason A Weesner, Diantha van de Vlekkert, Leigh Ellen Fremuth, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2023
AAV-mediated gene therapy for SialidosisDiantha van de Vlekkert, Huimin Hu, Leigh E Fremuth, et al.
Journal of Neuroinflammation|May 16, 2020
Two forms of CX3CL1 display differential activity and rescue cognitive deficits in CX3CL1 knockout miceAimee N Winter, Meena S Subbarayan, Bethany Grimmig, et al.
The Journal of Biological Chemistry|August 28, 2022
Distinct functions of dimeric and monomeric scaffold protein Alix in regulating F-actin assembly and loading of exosomal cargoXiaohui Qiu, Yvan Campos, Diantha van de Vlekkert, et al.
Molecular Therapy. Methods & Clinical Development|December 13, 2021
AAV-mediated gene therapy for galactosialidosis: A long-term safety and efficacy studyHuimin Hu, Rosario Mosca, Elida Gomero, et al.
Biorxiv : the Preprint Server for Biology|July 28, 2023
Altered GM1 catabolism affects NMDAR-mediated Ca <sup>2+</sup> signaling at ER-PM junctions and increases synaptic spine formationJason A Weesner, Ida Annunziata, Diantha van de Vlekkert, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 26, 2024
AAV-mediated gene therapy for sialidosisDiantha van de Vlekkert, Huimin Hu, Jason A Weesner, et al.
Cell Reports|April 17, 2024
Altered GM1 catabolism affects NMDAR-mediated Ca<sup>2+</sup> signaling at ER-PM junctions and increases synaptic spine formation in a GM1-gangliosidosis modelJason A Weesner, Ida Annunziata, Diantha van de Vlekkert, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Methods in Enzymology|March 1, 2026
Imaging and quantifying organelle contact sites using a reversible splitFAST complementation systemJason A Weesner, Chi-Lun Chang
STAR Protocols|August 10, 2024
Protocol for the isolation and purification of endoplasmic reticulum-plasma membrane junctions from the mouse brainJason A Weesner, Diantha van de Vlekkert, Leigh Ellen Fremuth, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2023
AAV-mediated gene therapy for SialidosisDiantha van de Vlekkert, Huimin Hu, Leigh E Fremuth, et al.
Journal of Neuroinflammation|May 16, 2020
Two forms of CX3CL1 display differential activity and rescue cognitive deficits in CX3CL1 knockout miceAimee N Winter, Meena S Subbarayan, Bethany Grimmig, et al.
The Journal of Biological Chemistry|August 28, 2022
Distinct functions of dimeric and monomeric scaffold protein Alix in regulating F-actin assembly and loading of exosomal cargoXiaohui Qiu, Yvan Campos, Diantha van de Vlekkert, et al.
Molecular Therapy. Methods & Clinical Development|December 13, 2021
AAV-mediated gene therapy for galactosialidosis: A long-term safety and efficacy studyHuimin Hu, Rosario Mosca, Elida Gomero, et al.
Biorxiv : the Preprint Server for Biology|July 28, 2023
Altered GM1 catabolism affects NMDAR-mediated Ca <sup>2+</sup> signaling at ER-PM junctions and increases synaptic spine formationJason A Weesner, Ida Annunziata, Diantha van de Vlekkert, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 26, 2024
AAV-mediated gene therapy for sialidosisDiantha van de Vlekkert, Huimin Hu, Jason A Weesner, et al.
Cell Reports|April 17, 2024
Altered GM1 catabolism affects NMDAR-mediated Ca<sup>2+</sup> signaling at ER-PM junctions and increases synaptic spine formation in a GM1-gangliosidosis modelJason A Weesner, Ida Annunziata, Diantha van de Vlekkert, et al.
Pageof 1